Advertisement

Advertisement

MAIA Stock Latest News

MAIA Biotechnology doses first U.S. patient in THIO-101 trial expansion

The FlyMAIA Biotechnology doses first U.S. patient in THIO-101 trial expansion

MAIA Biotechnology files $150M mixed securities shelf

PremiumThe Fly

MAIA Biotechnology files $150M mixed securities shelf

1M ago

MAIA Biotechnology reports efficacy data from Phase 2 THIO-101 Part C expansion

PremiumThe Fly

MAIA Biotechnology reports efficacy data from Phase 2 THIO-101 Part C expansion

3M ago

MAIA Biotechnology opens third clinical site in U.S. for Phase 2 THIO-101 trial

PremiumThe Fly

MAIA Biotechnology opens third clinical site in U.S. for Phase 2 THIO-101 trial

3M ago

MAIA Biotechnology reports 29 patients dosed in Phase 3 THIO-104 trial

PremiumThe Fly

MAIA Biotechnology reports 29 patients dosed in Phase 3 THIO-104 trial

4M ago

MAIA Biotechnology receives FDA clearance for amendment to IND application

PremiumThe FlyMAIA Biotechnology receives FDA clearance for amendment to IND application

4M ago

MAIA Biotechnology announces open market purchases by CEO, director

The Fly

MAIA Biotechnology announces open market purchases by CEO, director

4M ago

MAIA Biotechnology Shareholders Back Board and Auditor Appointments

Company Announcements

MAIA Biotechnology Shareholders Back Board and Auditor Appointments

4M ago

MAIA Biotechnology Ends ATM Stock Offering Agreement

PremiumCompany Announcements

MAIA Biotechnology Ends ATM Stock Offering Agreement

4M ago

MAIA Expands THIO-101 Lung Cancer Trial in U.S.

PremiumCompany Announcements

MAIA Expands THIO-101 Lung Cancer Trial in U.S.

5M ago

MAIA Fully Funds Pivotal Phase 3 THIO-104 NSCLC Trial

PremiumCompany Announcements

MAIA Fully Funds Pivotal Phase 3 THIO-104 NSCLC Trial

6M ago

MAIA Biotechnology secures funding for clinical trial of ateganosine

PremiumThe Fly

MAIA Biotechnology secures funding for clinical trial of ateganosine

6M ago

MAIA Biotechnology Awards Executive Bonuses After Successful Financing

PremiumCompany AnnouncementsMAIA Biotechnology Awards Executive Bonuses After Successful Financing

6M ago

MAIA Highlights Promising Phase 2 NSCLC Survival Outcomes

Company Announcements

MAIA Highlights Promising Phase 2 NSCLC Survival Outcomes

6M ago

MAIA Showcases THIO-101 NSCLC Data at ELCC 2026

Company Announcements

MAIA Showcases THIO-101 NSCLC Data at ELCC 2026

6M ago

MAIA Biotechnology Completes $30 Million Public Stock Offering

PremiumCompany Announcements

MAIA Biotechnology Completes $30 Million Public Stock Offering

7M ago

MAIA Biotechnology 20M share Spot Secondary priced at $1.50

PremiumThe Fly

MAIA Biotechnology 20M share Spot Secondary priced at $1.50

7M ago

MAIA Biotechnology announces common stock offering, no amount given

PremiumThe Fly

MAIA Biotechnology announces common stock offering, no amount given

7M ago

MAIA Biotechnology Highlights Progress in Phase 3 Oncology Program

PremiumCompany Announcements

MAIA Biotechnology Highlights Progress in Phase 3 Oncology Program

7M ago

MAIA Biotechnology published a 2026 Letter to Shareholders

PremiumThe FlyMAIA Biotechnology published a 2026 Letter to Shareholders

7M ago

MAIA Biotechnology outlines 2026 goals for ateganosine program

Company Announcements

MAIA Biotechnology outlines 2026 goals for ateganosine program

8M ago

MAIA Biotechnology highlights milestones, catalysts for FY26

The Fly

MAIA Biotechnology highlights milestones, catalysts for FY26

8M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >